This simple truth drove development of TruQ bioengineered tissue microarray controls to help laboratories deliver reliable results.
Until now, laboratories have not had access to a satisfactory commercially-available control to meet CAP recommendations for on-slide positive and negative controls with each test.1
As targeted therapies dependent on accurate visual scoring become increasingly common in cancer treatment protocols, laboratories need consistent controls to benchmark assay performance and standardize IHC testing.
While improvements have focused to date on IHC proficiency testing and guidelines for assay validation, consistent biomarker expression in controls used in validation and testing is essential.
Tissue control profiles are known to vary. Cell line controls don’t look like tissue. TruQ bioengineered TMA controls are the answer.
Learn how TruQ Controls can support
QA in your laboratory.